We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+18.7%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$272M
AUM Growth
–
Cap. Flow
+$259M
Cap. Flow %
95.26%
Top 10 Hldgs %
43.3%
Holding
71
New
71
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$9.27M
2
EW icon
Edwards Lifesciences
EW
+$9.04M
3
BSX icon
Boston Scientific
BSX
+$7.67M
4
RMD icon
ResMed
RMD
+$7.46M
5
ALIM
Alimera Sciences
ALIM
+$5.16M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 32.64%
2 Financials 0.78%
3 Utilities 0.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MD icon
51
Pediatrix Medical
MD
$2.12B
$1.65M 0.61%
+25,000
New +$1.53M
PODD icon
52
Insulet
PODD
$9.91B
$1.64M 0.6%
+35,500
New +$1.52M
AVNR
53
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$1.48M 0.55%
+87,500
New +$1.23M
MR
54
DELISTED
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
$1.32M 0.49%
+50,000
New +$1.46M
ALIM
55
CALL
DELISTED
Alimera Sciences
ALIM
$1.14M 0.42%
+13,667
New +$1.11M
RPTP
56
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$1.05M 0.39%
+100,000
New +$977K
CPRX
57
DELISTED
Catalyst Pharmaceutical
CPRX
$936K 0.34%
+315,000
New +$864K
ALXN
58
DELISTED
Alexion Pharmaceuticals
ALXN
$902K 0.33%
+4,875
New +$903K
AGN
59
DELISTED
Allergan plc
AGN
$882K 0.32%
+3,425
New +$856K
JAZZ icon
60
Jazz Pharmaceuticals
JAZZ
$16.7B
$819K 0.3%
+5,000
New +$830K
SGYP
61
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$763K 0.28%
+250,000
New +$739K
VNDA icon
62
Vanda Pharmaceuticals
VNDA
$304M
$716K 0.26%
+50,000
New +$592K
EIGR
63
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$656K 0.24%
+75
New +$435K
OCRX
64
DELISTED
Ocera Therapeutics, Inc.
OCRX
$478K 0.18%
+75,000
New +$439K
TLOG
65
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
$388K 0.14%
+80,500
New +$360K
JUNO
66
DELISTED
Juno Therapeutics, Inc.
JUNO
$326K 0.12%
+6,250
New +$280K
ESPR
67
DELISTED
Esperion Therapeutics
ESPR
$314K 0.12%
+7,760
New +$238K
GERN icon
68
Geron
GERN
$949M
$254K 0.09%
+78,200
New +$216K
CRMD icon
69
CorMedix
CRMD
$591M
$127K 0.05%
+13,350
New +$106K
1 2
3

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SR
Swiss Re Zurich, Switzerland $16.4M AUM
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return

Pura Vida Investments's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for Pura Vida Investments, which disclosed 71 positions worth $272M. Its ten largest holdings account for 43% of the portfolio.

Its largest position is Intuitive Surgical: 166,500 shares worth $9.79M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, followed by Financials and Utilities.

  • Pura Vida Investments's largest Q4 2014 buy was Intuitive Surgical: 166,500 shares worth $9.79M.
  • Pura Vida Investments's ten largest holdings make up 43% of its $272M portfolio in Q4 2014.
  • Pura Vida Investments disclosed 71 positions in Q4 2014, its first 13F filing on record.

Based on Pura Vida Investments's 13F filing for Q4 2014, filed 17 Feb 2015.